{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:04:52Z","timestamp":1787742292670,"version":"build-2784847793"},"reference-count":84,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jinf.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T02:17:26Z","timestamp":1477275446000},"page":"60-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Estimating the burden of invasive and serious fungal disease in the United Kingdom"],"prefix":"10.1016","volume":"74","author":[{"given":"Matthew","family":"Pegorie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Welfare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.10.005_bib1","article-title":"Voluntary surveillance of candidaemia in England, Wales and Northern Ireland: 2012","author":"Public Health England (PHE)","year":"2013","journal-title":"HPA"},{"key":"10.1016\/j.jinf.2016.10.005_bib2","unstructured":"http:\/\/www.neonin.org.uk\/index."},{"issue":"3","key":"10.1016\/j.jinf.2016.10.005_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0950268801005507","article-title":"Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990\u20139)","volume":"126","author":"Lamagni","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2016.10.005_bib4","unstructured":"http:\/\/www.hpa.org.uk\/webc\/hpawebfile\/hpaweb_c\/1196942156347 [Now archived: http:\/\/webarchive.nationalarchives.gov.uk\/20080728173910\/http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1194947363235]."},{"issue":"Suppl. 3","key":"10.1016\/j.jinf.2016.10.005_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.jinf.2016.10.005_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl. 7","key":"10.1016\/j.jinf.2016.10.005_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jinf.2016.10.005_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bjd.13358","article-title":"British Association of Dermatologists' guidelines for the management of onychomycosis 2014","volume":"171","author":"Ameen","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jinf.2016.10.005_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","article-title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","volume":"15","author":"Schelenz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2016.10.005_bib10","series-title":"2011 Census: population estimates for the United Kingdom, March 2011","author":"Office for National Statistics","year":"2012"},{"key":"10.1016\/j.jinf.2016.10.005_bib11","series-title":"Organ donation and transplantation activity report 2013\/14","year":"2014"},{"issue":"4","key":"10.1016\/j.jinf.2016.10.005_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1010-7940(01)00900-9","article-title":"Pneumocystis carinii pneumonia in heart transplant recipients","volume":"20","author":"Cardenal","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"10.1016\/j.jinf.2016.10.005_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1399-3062.2012.00740.x","article-title":"Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past","volume":"14","author":"Wang","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2016.10.005_bib14","doi-asserted-by":"crossref","DOI":"10.3201\/eid1903.121151","article-title":"Increasing Pneumocystis pneumonia, England, UK, 2000\u20132010","author":"Maini","year":"2013","journal-title":"Emerg Infect Dis [Internet]"},{"issue":"4","key":"10.1016\/j.jinf.2016.10.005_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(13)70332-3","article-title":"Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004\u201311: an observational study","volume":"14","author":"Okike","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2016.10.005_bib16","series-title":"HIV in the United Kingdom: 2014 report","author":"Public Health England (PHE)","year":"2014"},{"key":"10.1016\/j.jinf.2016.10.005_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2012.09.014","article-title":"The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a southwest London cohort","volume":"66","author":"Patel","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.10.005_bib18","series-title":"BSBMT registry: 2013 activity","author":"The British Society of Blood and Marrow Transplantation (BSBMT)","year":"2013"},{"key":"10.1016\/j.jinf.2016.10.005_bib19","unstructured":"UK Cancer Registry, accessed via Cancer Research UK CancerStats web page: http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/."},{"key":"10.1016\/j.jinf.2016.10.005_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","article-title":"Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry","volume":"152","author":"Jones","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2016.10.005_bib21","article-title":"Emergency Inpatient admissions for COPD in England based on hospital episode Statistics (HES) 2005\u20132008","author":"DiSantostefano","year":"2011","journal-title":"Am Thorac Soc Int Conf Abstr"},{"key":"10.1016\/j.jinf.2016.10.005_bib22","series-title":"Hospital Episode Statistics, adult critical care in England: April 2013 to March 2014","author":"HES online and the NHS Information Centre (NHSIC)","year":"2015"},{"issue":"12","key":"10.1016\/j.jinf.2016.10.005_bib23","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2016.10.005_bib24","series-title":"Health Protection (HPA) mycology network \u2013 rapid evaluation of incidence estimates (unpublished)","author":"Keshishian","year":"2004"},{"key":"10.1016\/j.jinf.2016.10.005_bib25","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2016.10.005_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/INF.0b013e3181f13b23","article-title":"Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease a multicenter study in France","volume":"30","author":"Beaute","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.jinf.2016.10.005_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2016.10.005_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1469-0691.2011.03503.x","article-title":"Invasive pulmonary\u00a0aspergillosis in patients with chronic obstructive\u00a0pulmonary disease: a case control study from China","volume":"18","author":"Xu","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jinf.2016.10.005_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.jinf.2016.10.005_bib30","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/cncr.24559","article-title":"Clinical characteristics\u00a0of 45 patients with invasive pulmonary aspergillosis:\u00a0retrospective analysis of 1711 lung cancer cases","volume":"115","author":"Yan","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2016.10.005_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jinf.2016.10.005_bib32","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jinf.2016.10.005_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s001340000768","article-title":"Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?","volume":"27","author":"Bulpa","year":"2001","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2016.10.005_bib34","first-page":"864","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to tuberculosis","volume":"89","author":"Denning","year":"2011","journal-title":"Bull WHO"},{"key":"10.1016\/j.jinf.2016.10.005_bib35","first-page":"1059","article-title":"The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse","volume":"12","author":"Hamilton","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2016.10.005_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejrad.2007.07.009","article-title":"High resolution chest CT in patients with pulmonary tuberculosis: characteristic findings before and after antituberculous therapy","volume":"67","author":"Lee","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jinf.2016.10.005_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1590\/S1516-31802003000500004","article-title":"Pulmonary tuberculosis: tomographic evaluation in the active and post-treatment phases","volume":"121","author":"Bombarda","year":"2003","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.jinf.2016.10.005_bib38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"Denning","year":"2013","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jinf.2016.10.005_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying pulmonary disease frequency in patients with chronic pulmonary aspergillosis","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jinf.2016.10.005_bib40","unstructured":"NHS England National Commissioning Group Chronic Pulmonary Aspergillosis national service. The National Aspergillosis Centre Annual Report 2013\u20132014. http:\/\/www.nationalaspergillosiscentre.org.uk\/."},{"key":"10.1016\/j.jinf.2016.10.005_bib41","unstructured":"Public Health England. Public Health Outcomes Framework. http:\/\/www.phoutcomes.info\/public-health-outcomes-framework#page\/3\/gid\/1000044\/pat\/6\/par\/E12000002\/ati\/102\/are\/E06000008\/iid\/40701\/age\/163\/sex\/4."},{"key":"10.1016\/j.jinf.2016.10.005_bib42","series-title":"Annual mid-year population estimates: 2014","author":"Office for National Statistics","year":"2015"},{"key":"10.1016\/j.jinf.2016.10.005_bib43","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jinf.2016.10.005_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2016.10.005_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jinf.2016.10.005_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1258\/jrsm.2009.090027","article-title":"Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases","volume":"102","author":"Anandan","year":"2009","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jinf.2016.10.005_bib47","series-title":"Prevalence of possible Severe Asthma with Fungal Sensitisation (SAFS) and Allergic Bronchopulmonary Aspergillosis (ABPA) in a UK secondary care hospital","author":"Lee","year":"2013"},{"issue":"1, 2","key":"10.1016\/j.jinf.2016.10.005_bib48","first-page":"39","article-title":"Diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients","volume":"3","author":"Varshokar","year":"2001","journal-title":"J Semnan Univ Med Sci"},{"issue":"5","key":"10.1016\/j.jinf.2016.10.005_bib49","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1111\/apa.12930","article-title":"The diagnostic criteria for allergic bronchopulmonary aspergillosis in children with poorly controlled asthma need to be re-evaluated","volume":"104","author":"Singh","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jinf.2016.10.005_bib50","series-title":"UK cystic fibrosis registry annual data report 2011","author":"Cystic Fibrosis Trust","year":"2013"},{"key":"10.1016\/j.jinf.2016.10.005_bib51","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2016.10.005_bib52","series-title":"UK cystic fibrosis registry annual data report 2012","author":"Cystic Fibrosis Trust","year":"2013"},{"issue":"1","key":"10.1016\/j.jinf.2016.10.005_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","article-title":"Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study","volume":"179","author":"Denning","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.jinf.2016.10.005_bib54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1440-1843.2009.01640.x","article-title":"The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis","volume":"14","author":"Pasqualotto","year":"2009","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.jinf.2016.10.005_bib55","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1183\/09031936.00030711","article-title":"Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?","volume":"38","author":"Bush","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jinf.2016.10.005_bib56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/02770903.2012.662568","article-title":"Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization","volume":"49","author":"Chishimba","year":"2012","journal-title":"J Asthma"},{"issue":"2","key":"10.1016\/j.jinf.2016.10.005_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.01.016","article-title":"Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33","volume":"136","author":"Castanhinha","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2016.10.005_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/bmj.325.7361.411","article-title":"Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey","volume":"325","author":"Zureik","year":"2002","journal-title":"Br Med J"},{"issue":"50","key":"10.1016\/j.jinf.2016.10.005_bib59","first-page":"847","article-title":"Severe asthma: definition, diagnosis and treatment","volume":"111","author":"Lommatzsch","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jinf.2016.10.005_bib60","article-title":"The prevalence of severe refractory asthma","author":"Hekking","year":"2014","journal-title":"Am Acad Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2016.10.005_bib61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2466-5-4","article-title":"Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions","volume":"18","author":"O'Driscoll","year":"2005","journal-title":"BMC Pulm Med"},{"issue":"8","key":"10.1016\/j.jinf.2016.10.005_bib62","first-page":"936","article-title":"Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis","volume":"13","author":"Agarwal","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"10.1016\/j.jinf.2016.10.005_bib63","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1365-2222.2009.03339.x","article-title":"Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma","volume":"39","author":"O'Driscoll","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jinf.2016.10.005_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-7022-4-14","article-title":"Fungal allergy in asthma-state of the art and research needs","volume":"4","author":"Denning","year":"2014","journal-title":"Clin Transl Allergy"},{"issue":"36","key":"10.1016\/j.jinf.2016.10.005_bib65","article-title":"Voluntary surveillance of candidaemia in England, Wales and Northern Ireland: 2013","volume":"8","author":"Public Health England","year":"2014","journal-title":"Health Prot Rep Wkly Rep"},{"key":"10.1016\/j.jinf.2016.10.005_bib66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","author":"Avni","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.jinf.2016.10.005_bib67","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/cis200","article-title":"Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis","volume":"54","author":"Nguyen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.10.005_bib68","series-title":"NICE clinical guideline 125: kidney disease: peritoneal dialysis: costing report, implementing NICE guidance","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2011"},{"key":"10.1016\/j.jinf.2016.10.005_bib69","unstructured":"Leading International Fungal Education (LIFE) website: http:\/\/www.life-worldwide.org\/fungal-diseases\/candida-peritonitis\/ last accessed on 01.07.13."},{"issue":"10","key":"10.1016\/j.jinf.2016.10.005_bib70","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/QAD.0b013e32833a3967","article-title":"AIDS-defining opportunistic illnesses in US patients, 1994\u20132007: a cohort study","volume":"24","author":"Buchacz","year":"2010","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jinf.2016.10.005_bib71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.respe.2012.03.007","article-title":"Estimating the burden of mucormycosis infections in France (2005\u20132007) through a capture-recapture method on laboratory and administrative data","volume":"60","author":"Bitar","year":"2012","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"7","key":"10.1016\/j.jinf.2016.10.005_bib72","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2016.10.005_bib73","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2016.10.005_bib74","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc3488","article-title":"Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation outcome","volume":"9","author":"Garnacho-Montero","year":"2005","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.jinf.2016.10.005_bib75","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmjqs-2012-000803","article-title":"Diagnostic errors in the intensive care unit: a systematic review of autopsy studies","volume":"21","author":"Winters","year":"2012","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jinf.2016.10.005_bib76","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02948415","article-title":"Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985\u201388","volume":"160","author":"Donnelly","year":"1991","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jinf.2016.10.005_bib77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaci.2009.06.011","article-title":"Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005\u20132006","volume":"124","author":"Gergen","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2016.10.005_bib78","series-title":"Why asthma still kills, The National Review of Asthma Deaths (NRAD). Confidential enquiry report","author":"Royal College of Physicians","year":"2014"},{"issue":"Pt 8","key":"10.1016\/j.jinf.2016.10.005_bib79","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1099\/jmm.0.47239-0","article-title":"One year prospective survey of Candida bloodstream infections in Scotland","volume":"56","author":"Odds","year":"2007","journal-title":"J Med Microbiol"},{"issue":"Pt 4","key":"10.1016\/j.jinf.2016.10.005_bib80","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/jmm.0.000020","article-title":"Burden of fungal disease in Ireland","volume":"64","author":"Dorgan","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jinf.2016.10.005_bib81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0195-6701(03)00085-9","article-title":"Management and outcome of bloodstream infections due to Candida species in England and Wales","volume":"54","author":"Kibbler","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jinf.2016.10.005_bib82","series-title":"Health and Social Care information Centre. Hospital Episode Statistics. Admitted patient care, England 2104\u201315","author":"Hospital Episode Statistics Analysis","year":"2015"},{"issue":"5","key":"10.1016\/j.jinf.2016.10.005_bib83","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/13993003.00780-2015","article-title":"The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts","volume":"46","author":"Fleming","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2016.10.005_bib84","unstructured":"http:\/\/www.gaffi.org\/media\/academic-papers\/."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316302730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316302730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:48Z","timestamp":1759008228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316302730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0163445316302730"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.10.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the burden of invasive and serious fungal disease in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}